Ilaria Alborelli

11PUBLICATIONS
81CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 11, 2026
TCR γδ cell-specific STAT5 gain of function induces a druggable chronic human immune dysregulation.

|Jul 13, 2026
A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy.

|Sep 30, 2025
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy.

Dominic Schmid, Bettina Sobottka, Massimiliano Manzo

|Aug 29, 2024
Both Maternal High-Fat and Post-Weaning High-Carbohydrate Diets Increase Rates of Spontaneous Hepatocellular Carcinoma in Aged-Mouse Offspring.

Daniel Holt, Laura Contu, Alice Wood

|Aug 17, 2023
Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17.

Richard Cathomas, Sacha I Rothschild, Stefanie Hayoz

|Sep 10, 2021
The Long Non-Coding RNA H19 Drives the Proliferation of Diffuse Intrinsic Pontine Glioma with H3K27 Mutation.

David Roig-Carles, Holly Jackson, Katie F Loveson

Pageof 2

Frequent Collaborators

3 joint publications

Sacha I Rothschild

2 joint publications

Nicolas Mach

2 joint publications

Stefanie Hayoz

2 joint publications

Katharina Leonards